OPTIMER PHARMACEUTICALS INC License Costs (Deprecated 2018-01-31)
OPTIMER PHARMACEUTICALS INC reported License Costs (Deprecated 2018-01-31) of $7.58 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LicenseCosts · last filed 2012-05-10
- OPTIMER PHARMACEUTICALS INC license costs (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $3.31M.
- OPTIMER PHARMACEUTICALS INC license costs (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $0.00.
- OPTIMER PHARMACEUTICALS INC license costs (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $0.00.
- OPTIMER PHARMACEUTICALS INC license costs (deprecated 2018-01-31) for the quarter ending 2011-03-31 was $4.27M.
- OPTIMER PHARMACEUTICALS INC license costs (deprecated 2018-01-31) for fiscal 2011 was $7.58M.
| Period end | License Costs (Deprecated 2018-01-31) 3 month | License Costs (Deprecated 2018-01-31) 6 month | License Costs (Deprecated 2018-01-31) 9 month | License Costs (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2011-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-08 | $3.31M derived: sum of 2 quarters · filed 2012-03-08 | $3.31M derived: sum of 3 quarters · filed 2012-03-08 | $7.58M 10-K · filed 2012-03-08 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $0.00 derived: sum of 2 quarters · filed 2011-11-03 | $4.27M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $4.27M 10-Q · filed 2011-08-04 | ||
| 2011-03-31 | $4.27M 10-Q · filed 2012-05-10 |